You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Pemetrexed

Showing 1 - 25 of 1,179
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC Metastatic Trial (Atezolizumab, Nab paclitaxel, Carboplatin)

Not yet recruiting
  • Non-Small Cell Lung Cancer Metastatic
  • (no location specified)
Jan 18, 2023

NSCLC, Epidermal Growth Factor Receptor, Leptomeningeal Metastasis Trial (Pemetrexed)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +2 more
  • Pemetrexed
  • (no location specified)
Mar 27, 2023

NSCLC Associated With Leptomeningeal Metastases Trial (Tislelizumab, pemetrexed)

Not yet recruiting
  • NSCLC Associated With Leptomeningeal Metastases
  • Tislelizumab, pemetrexed
  • (no location specified)
Nov 21, 2023

NSCLC, Mesothelioma, Thymoma Trial in Breda, Dordrecht (Folinic acid)

Recruiting
  • NSCLC
  • +2 more
  • Folinic acid
  • Breda, Noord Brabant, Netherlands
  • +1 more
Aug 17, 2023

Non-squamous Non-small-cell Lung Cancer Trial in Hangzhou (Tusamitamab ravtansine+Sintilimab+Carboplatin or

Not yet recruiting
  • Non-squamous Non-small-cell Lung Cancer
  • Tusamitamab ravtansine+Sintilimab+Carboplatin or Cisplatin+Pemetrexed
  • +2 more
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
May 5, 2023

NSCLC Trial in Seoul (Lazertinib/Pemetrexed/Carboplatin)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Mar 23, 2023

Leptomeningeal Metastases Trial in Changchun (Pemetrexed (1), Pemetrexed (2), Folic Acid)

Recruiting
  • Leptomeningeal Metastases
  • Pemetrexed (1)
  • +4 more
  • Changchun, Jilin, China
    The First Hospital of Jilin University
Sep 29, 2022

NSCLC Trial in Pittsburgh (Tiragolumab, Atezolizumab, Pemetrexed)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Feb 16, 2023

Malignant Pleural Mesothelioma Trial in Edegem, Ghent, Sint-Niklaas (Dendritic cell vaccination, Atezolizumab,

Not yet recruiting
  • Malignant Pleural Mesothelioma
  • Dendritic cell vaccination
  • +2 more
  • Edegem, Antwerp, Belgium
  • +2 more
Feb 28, 2023

Primary CNS Lymphoma, Secondary CNS Lymphoma, Relapsed Cancer Trial in Miami (drug, procedure, radiation)

Not yet recruiting
  • Primary Central Nervous System Lymphoma
  • +3 more
  • Pemetrexed
  • +3 more
  • Miami, Florida
    Miami Cancer Institute at Baptist Health, Inc.
Dec 23, 2022

Non Small Cell Lung Cancer, Immune Checkpoint Inhibitor, EGFR Exon 21 Mutation Trial in Peking (Pembrolizumab, pemetrexed,

Not yet recruiting
  • Non Small Cell Lung Cancer
  • +2 more
  • Peking, China
    Peking Union Medical College Hospital
Nov 16, 2023

Sarcoma Trial in Seoul (Pemetrexed, cisplatin)

Active, not recruiting
  • Sarcoma
  • Pemetrexed, cisplatin
  • Seoul, Korea, Republic of
    Severance Hospital, Yonsei University Health System
May 30, 2022

Non Small Cell Lung Cancer, Mesothelioma Trial in Netherlands (Pemetrexed)

Recruiting
  • Non Small Cell Lung Cancer
  • Mesothelioma
  • Pemetrexed
  • 's-Hertogenbosch, Netherlands
  • +4 more
Sep 9, 2022

NSCLC (NSCLC) Trial (MK-2870, Docetaxel, Pemetrexed)

Not yet recruiting
  • Non-small Cell Lung Cancer (NSCLC)
  • MK-2870
  • +2 more
  • (no location specified)
Oct 3, 2023

Pleural Mesothelioma Trial in Italy (Carboplatin/Cisplatin - Pemetrexed - Pembrolizumab)

Not yet recruiting
  • Pleural Mesothelioma
  • Carboplatin/Cisplatin - Pemetrexed - Pembrolizumab
  • Rozzano, MI, Italy
  • +5 more
Nov 30, 2023

NSCLC Trial (SKB264, Pemetrexed, Carboplatin)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • (no location specified)
May 23, 2023

Leptomeningeal Metastasis Trial in Changchun (Pemetrexed, Radiotherapy)

Recruiting
  • Leptomeningeal Metastasis
  • Pemetrexed
  • Radiotherapy
  • Changchun, Jilin, China
    The First Hospital of Jilin University
Jun 8, 2022

Non-Small-Cell Lung Carcinoma Trial (biological, drug, dietary supplement)

Active, not recruiting
Has Results
  • Non-Small-Cell Lung Carcinoma
  • Pembrolizumab 200 mg
  • +7 more
  • (no location specified)
Aug 16, 2022

Adenocarcinoma of Lung, NSCLC Trial in Rolling Meadows (LP-300, Pemetrexed, Carboplatin)

Not yet recruiting
  • Adenocarcinoma of Lung
  • Carcinoma, Non-Small-Cell Lung
  • (no location specified)
Jul 8, 2022

Carcinoma, Non-Small-Cell Lung Trial in Beijing (HLX10, an engineered anti-PD-1 antibody, HLX04, a bevacizumab biosimilar,

Recruiting
  • Carcinoma
  • Non-Small-Cell Lung
  • HLX10, an engineered anti-PD-1 antibody
  • +3 more
  • Beijing, Beijing, China
    Cancer Hospital Chinese Academy of Medical Sciences (CAMS)
Apr 29, 2022

Proton Pump Inhibitors and Hematologic Toxicity of Pemetrexed

Completed
  • Patients With Non-small Cell Lung Cancer (NSCLC) and Pleural Mesothelioma and Treated With a Pemetrexed-based Chemotherapy
  • pemetrexed-related hematological toxicity
  • Reims, France
    Chu Reims
Feb 11, 2022

Urothelial Carcinoma, Metastatic Cancer Trial in Houston (Pemetrexed, Zimberelimab, Etrumadenant)

Not yet recruiting
  • Urothelial Carcinoma
  • Metastatic Cancer
  • Pemetrexed
  • +2 more
  • Houston, Texas
    MD Anderson Cancer Center
Nov 28, 2022

Mesothelioma Trial in Houston (Pemetrexed, Cisplatin)

Terminated
  • Mesothelioma
  • Houston, Texas
    Baylor St Lukes
Mar 15, 2022

Lung Cancer Trial in Houston (AMG 510, Cisplatin, Carboplatin)

Recruiting
  • Lung Cancer
  • AMG 510
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 10, 2022

Nonsquamous Nonsmall Cell Tumor of Lung Trial in Taipei (BLEX 404)

Not yet recruiting
  • Nonsquamous Nonsmall Cell Neoplasm of Lung
  • BLEX 404
  • Taipei, Taiwan
    Taipei Veteran General Hospital
Feb 28, 2023